Furong Kou

4PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 07, 2026
Second-line raltitrexed plus irinotecan (SALIRI) with bevacizumab, cetuximab, or alone for metastatic colorectal cancer: a prospective multicenter cohort-based secondary analysis of the SALLY trial.

|Mar 26, 2025
Clinical Impact and Genomic Features of Human Epidermal Growth Factor Receptor 2-Low Tumors in BRCA1/2-Mutated Triple-Negative Breast Cancer.

Furong Kou, Huimin Liu, Yaxin Zhang

|Apr 21, 2023
Pyrotinib alone or in combination with docetaxel in refractory HER2-positive gastric cancer: A dose-escalation phase I study.

Dan Liu, Furong Kou, Jifang Gong

|Feb 22, 2021
Phase I study of intraperitoneal bevacizumab for treating refractory malignant ascites.

Furong Kou, Jifang Gong, Yan Li

Pageof 1

Frequent Collaborators

1 joint publications

Jian Li

1 joint publications

Jun Zhou

1 joint publications

Zhihao Lu

1 joint publications

Lin Shen